國立虎尾科技大學 |

Renal Pharmacotherapy = Dosage Adjustment of Medications Eliminated by the Kidneys /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Renal Pharmacotherapy/ by Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H. Kiser, Gerard R. Barber, Nancy M. Stolpman.
Reminder of title:	Dosage Adjustment of Medications Eliminated by the Kidneys /
Author:	Golightly, Larry K.
other author:	Teitelbaum, Isaac.
Description:	XXVI, 827 p. 2 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Nephrology. -
Online resource:	https://doi.org/10.1007/978-3-030-58650-8
ISBN:	9783030586508

Renal Pharmacotherapy = Dosage Adjustment of Medications Eliminated by the Kidneys /
Golightly, Larry K.

Renal PharmacotherapyDosage Adjustment of Medications Eliminated by the Kidneys /[electronic resource] :by Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H. Kiser, Gerard R. Barber, Nancy M. Stolpman. - 2nd ed. 2021. - XXVI, 827 p. 2 illus.online resource.

A: Acamprosate to Aztreonam -- B: Bacitracin to Butorphanol -- : Capecitabine to Cycloserine -- D: Dabigatran to Dyphylline -- E: Edetate Calcium Disodium to Exenatide -- F: Famciclovir to Fosfomycin -- H: Hetastarch to Hydroxyurea -- I: Ibandronate to Itraconazole -- K: Kanamycin to Ketorolac -- L: Lacosamide to Lurasidone -- M: Magnesium Citrate to Mycophenolate Mofetil -- N: Nabumetone to Norfloxacin -- O: Ofloxacin to Oxcarbazepine -- P: Paliperidone to Pyridostigmine -- Q: Quinapril to Quinine -- R: Ramipril to Ruxolitinib -- S: Salsalate to Sunitinib -- T: Tadalafil to Trospium -- V: Valacyclovir to Voriconazole -- Z: Zalcitabine to Zonisamide -- Proprietary Name Index.

To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.

ISBN: 9783030586508

Standard No.: 10.1007/978-3-030-58650-8doiSubjects--Topical Terms:

668354
Nephrology.

LC Class. No.: RC902-918

Dewey Class. No.: 616.61

Renal Pharmacotherapy = Dosage Adjustment of Medications Eliminated by the Kidneys /
LDR:03098nam a22003855i 4500 001 1051303
003 DE-He213
005 20210924160542.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030586508 $9 978-3-030-58650-8
024 7 $a 10.1007/978-3-030-58650-8 $2 doi
035 $a 978-3-030-58650-8
050 4 $a RC902-918
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
072 7 $a MJR $2 thema
082 0 4 $a 616.61 $2 23
100 1 $a Golightly, Larry K. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1074940
245 1 0 $a Renal Pharmacotherapy $h [electronic resource] : $b Dosage Adjustment of Medications Eliminated by the Kidneys / $c by Larry K. Golightly, Isaac Teitelbaum, Bonita A. Simendinger, Tyree H. Kiser, Gerard R. Barber, Nancy M. Stolpman.
250 $a 2nd ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XXVI, 827 p. 2 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a A: Acamprosate to Aztreonam -- B: Bacitracin to Butorphanol -- : Capecitabine to Cycloserine -- D: Dabigatran to Dyphylline -- E: Edetate Calcium Disodium to Exenatide -- F: Famciclovir to Fosfomycin -- H: Hetastarch to Hydroxyurea -- I: Ibandronate to Itraconazole -- K: Kanamycin to Ketorolac -- L: Lacosamide to Lurasidone -- M: Magnesium Citrate to Mycophenolate Mofetil -- N: Nabumetone to Norfloxacin -- O: Ofloxacin to Oxcarbazepine -- P: Paliperidone to Pyridostigmine -- Q: Quinapril to Quinine -- R: Ramipril to Ruxolitinib -- S: Salsalate to Sunitinib -- T: Tadalafil to Trospium -- V: Valacyclovir to Voriconazole -- Z: Zalcitabine to Zonisamide -- Proprietary Name Index.
520 $a To promote effectiveness and minimize possible toxicity, the dosage of certain medications must be adjusted in persons with compromised kidney function. Failure to enjoin appropriate dosage adjustments in patients with abnormal or rapidly changing kidney function continues to lead to reports of drug toxicity involving a broad array of renally eliminated medications. This updated edition captures nearly 200 new drugs that have been approved by the FDA since the initial publication of Renal Pharmacotherapy. It also covers new evidence that has emerged regarding the need to adjust dosage of certain older medications that are eliminated by the kidneys. Additionally, it presents new data that are being continuously derived in the areas of patient-specific dose individualization for drugs of all types. Comprehensive, convenient, and evidence-based, this reference closes several identified knowledge gaps and will continue to be the leading collection of dosage recommendations for patients with compromised kidney function.
650 0 $a Nephrology. $3 668354
650 0 $a Pharmacology. $3 583819
650 0 $a Internal medicine. $3 644638
650 0 $a Pharmacotherapy. $3 973587
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Drug resistance. $3 872072
650 2 4 $a Pharmacology/Toxicology. $3 593882
650 2 4 $a Internal Medicine. $3 668583
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Drug Resistance. $3 782695
700 1 $a Teitelbaum, Isaac. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1355796
700 1 $a Simendinger, Bonita A. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1355797
700 1 $a Kiser, Tyree H. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1355798
700 1 $a Barber, Gerard R. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1355799
700 1 $a Stolpman, Nancy M. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1355800
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030586492
776 0 8 $i Printed edition: $z 9783030586515
856 4 0 $u https://doi.org/10.1007/978-3-030-58650-8
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)